➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Dow
Boehringer Ingelheim
Merck
Medtronic

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

METHYLPREDNISOLONE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for methylprednisolone and what is the scope of freedom to operate?

Methylprednisolone is the generic ingredient in eleven branded drugs marketed by Pfizer, Duramed Pharms Barr, Heather, Invatech, Jubilant Cadista, Lupin Ltd, Novast Labs, Par Pharm, Praxgen, Sandoz, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms, Pharmacia And Upjohn, Bel Mar, Akorn, Amneal, Sagent Pharms Inc, Sandoz Inc, Teva Pharms Usa, Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Teva Parenteral, and Tianjin Kingyork, and is included in eighty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for methylprednisolone. Thirty suppliers are listed for this compound.

Drug Prices for METHYLPREDNISOLONE

See drug prices for METHYLPREDNISOLONE

Drug Sales Revenue Trends for METHYLPREDNISOLONE

See drug sales revenues for METHYLPREDNISOLONE

Recent Clinical Trials for METHYLPREDNISOLONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital Inselspital, BernePhase 3
Rho Federal Systems Division, Inc.Phase 2
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2

See all METHYLPREDNISOLONE clinical trials

Pharmacology for METHYLPREDNISOLONE
Medical Subject Heading (MeSH) Categories for METHYLPREDNISOLONE

US Patents and Regulatory Information for METHYLPREDNISOLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040641-004 Feb 21, 2007 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Amneal METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 210043-001 May 20, 2019 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 040232-001 Oct 16, 1997 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Dow
Boehringer Ingelheim
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.